Highlights

KLSE: MHCARE (03005)

METRO HEALTHCARE BERHAD

Last Price	Today's Change	Day's Range	Trading Volume
0.62	0.00 (0.00%)	0.00 - 0.00	0

Analyze this stock with MQ Trader system

Financials

Market Cap: 382 Million

Market Cap	382 Million
NOSH	617 Million

Latest Audited Result: 31-Dec-2023

Latest Audited Result:	31-Dec-2023
Announcement Date	29-Feb-2024
Next Audited Result:	31-Dec-2024
Est. Ann. Date:	28-Feb-2025
Est. Ann. Due Date:	29-Jun-2025

Latest Quarter: 31-Dec-2023 [#2]

Latest Quarter:	31-Dec-2023 [#2]
Announcement Date	23-Feb-2024
Next Quarter:	31-Mar-2024
Est. Ann. Date:	23-May-2024
Est. Ann. Due Date:	30-May-2024
QoQ \| YoY	-8.05% \| 21.37%

Annual (Unaudited) ( EPS: 1.01, P/E: 61.20 )

Revenue \| NP to SH	44,686 \| 6,248
RPS \| P/RPS	7.25 Cent \| 8.56
EPS \| P/E \| EY	1.01 Cent \| 61.20 \| 1.63%
DPS \| DY \| Payout %	0.70 Cent \| 1.13% \| 69.09%
NAPS \| P/NAPS	0.06 \| 10.23
YoY	22.77%
NP Margin \| ROE	13.98% \| 16.72%
F.Y. \| Ann. Date	31-Dec-2023 \| 23-Feb-2024

T4Q Result ( EPS: 1.01, P/E: 61.20 )

Revenue \| NP to SH	44,686 \| 6,248
RPS \| P/RPS	7.25 Cent \| 8.56
EPS \| P/E \| EY	1.01 Cent \| 61.20 \| 1.63%
DPS \| DY \| Payout %	0.70 Cent \| 1.13% \| 69.09%
NAPS \| P/NAPS	0.06 \| 10.23
QoQ \| YoY	9.21% \| 22.77%
NP Margin \| ROE	13.98% \| 16.72%
F.Y. \| Ann. Date	31-Dec-2023 \| 23-Feb-2024

Annualized Result ( EPS: 1.01, P/E: 61.20 )

Revenue \| NP to SH	44,686 \| 6,248
RPS \| P/RPS	7.25 Cent \| 8.56
EPS \| P/E \| EY	1.01 Cent \| 61.20 \| 1.63%
DPS \| DY \| Payout %	-
NAPS \| P/NAPS	-
QoQ \| YoY	-4.02% \| 22.77%
NP Margin \| ROE	13.98% \| 16.72%
F.Y. \| Ann. Date	31-Dec-2023 \| 23-Feb-2024

Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date				Financial Result						Financial Ratio			Per Share Item									Performance		Valuation (End of Quarter)							Valuation (Ann. Date)
F.Y.	Ann. Date	Quarter	#	Revenue	PBT	NP	NP to SH	Div	Net Worth	Div Payout %	NP Margin	ROE	NOSH	RPS	Adj. RPS	EPS	Adj. EPS	DPS	Adj. DPS	NAPS	Adj. NAPS	QoQ	YoY	EOQ Date	EOQ Price	EOQ P/RPS	EOQ P/EPS	EOQ P/NAPS	EOQ EY	EOQ DY	ANN Date	ANN Price	ANN P/RPS	ANN P/EPS	ANN P/NAPS	ANN EY	ANN DY
31-Dec-2023	23-Feb-2024	31-Dec-2023	2	22,984	4,078	2,993	2,993	-	37,372	- %	13.02%	8.01%	616,710	3.73	3.73	0.49	0.49	0.00	0.00	0.0606	0.06	-8.05%	21.37%	29-Dec-2023	0.63	16.90	129.81	10.40	0.77%	0.00%	23-Feb-2024	0.63	16.90	129.81	10.40	0.77%	0.00%
31-Dec-2023	22-Aug-2023	30-Jun-2023	1	21,702	4,464	3,255	3,255	4,316	33,795	132.63%	15.00%	9.63%	616,710	3.52	3.52	0.53	0.53	0.70	0.70	0.0548	0.05	32.00%	24.09%	30-Jun-2023	0.63	17.90	119.36	11.50	0.84%	1.11%	22-Aug-2023	0.63	17.90	119.36	11.50	0.84%	1.11%
31-Dec-2022	27-Feb-2023	31-Dec-2022	2	20,767	4,099	2,466	2,466	-	35,337	- %	11.87%	6.98%	616,710	3.37	3.37	0.40	0.40	0.00	0.00	0.0573	0.06	-5.99%	-51.00%	30-Dec-2022	0.68	20.19	170.06	11.87	0.59%	0.00%	27-Feb-2023	0.65	19.30	162.56	11.34	0.62%	0.00%
31-Dec-2022	30-Aug-2022	30-Jun-2022	1	19,506	3,462	2,623	2,623	4,070	32,870	155.18%	13.45%	7.98%	616,710	3.16	3.16	0.43	0.43	0.66	0.66	0.0533	0.05	-47.88%	-39.84%	30-Jun-2022	0.68	21.50	159.88	12.76	0.63%	0.97%	30-Aug-2022	0.67	21.18	157.53	12.57	0.63%	0.99%
31-Dec-2021	22-Feb-2022	31-Dec-2021	2	21,433	6,655	5,033	5,033	1,910	16,257	37.97%	23.48%	30.96%	293,986	7.29	3.48	1.71	0.82	0.65	0.31	0.0553	0.03	15.44%	42.82%	31-Dec-2021	0.54	7.41	31.54	9.76	3.17%	1.20%		0.57	7.82	33.29	10.31	3.00%	1.14%
31-Dec-2021	26-Aug-2021	30-Jun-2021	1	20,824	6,221	4,360	4,360	1,328	28,672	30.47%	20.94%	15.21%	204,366	10.19	3.38	2.13	0.71	0.65	0.22	0.1403	0.05	23.72%	128.87%	30-Jun-2021	1.15	11.29	53.90	8.20	1.86%	0.57%	26-Aug-2021	1.00	9.81	46.87	7.13	2.13%	0.65%
31-Dec-2020	22-Feb-2021	31-Dec-2020	2	17,194	4,750	3,524	3,524	1,213	22,634	34.44%	20.50%	15.57%	202,270	8.50	2.79	1.74	0.57	0.60	0.20	0.1119	0.04	84.99%	184.42%	31-Dec-2020	1.08	12.71	61.99	9.65	1.61%	0.56%		0.00	0.00	0.00	0.00	0.00%	0.00%
31-Dec-2020	18-Aug-2020	30-Jun-2020	1	11,140	2,488	1,905	1,905	1,213	19,175	63.71%	17.10%	9.93%	202,270	5.51	1.81	0.95	0.31	0.60	0.20	0.0948	0.03	53.75%	79.55%	30-Jun-2020	0.97	17.61	102.99	10.23	0.97%	0.62%	18-Aug-2020	0.98	17.79	104.05	10.34	0.96%	0.61%
31-Dec-2019	20-Feb-2020	31-Dec-2019	2	11,708	1,588	1,239	1,239	1,103	17,055	89.07%	10.58%	7.26%	200,650	5.84	1.90	0.62	0.20	0.55	0.18	0.0850	0.03	16.78%	5.90%	31-Dec-2019	0.95	16.28	153.85	11.18	0.65%	0.58%	20-Feb-2020	1.01	17.31	163.56	11.88	0.61%	0.54%
31-Dec-2019	23-Aug-2019	30-Jun-2019	1	11,001	1,847	1,061	1,061	-	16,934	- %	9.64%	6.27%	200,650	5.48	1.78	0.53	0.17	0.00	0.00	0.0844	0.03	-9.32%	62.98%	28-Jun-2019	0.71	12.95	134.27	8.41	0.74%	0.00%	23-Aug-2019	0.74	13.50	139.94	8.77	0.71%	0.00%
31-Dec-2018	28-Feb-2019	31-Dec-2018	2	10,454	1,165	1,170	1,170	-	15,651	- %	11.19%	7.48%	197,869	5.28	1.70	0.58	0.19	0.00	0.00	0.0791	0.03	79.72%	-22.57%	31-Dec-2018	0.50	9.46	84.56	6.32	1.18%	0.00%	28-Feb-2019	0.48	9.09	81.18	6.07	1.23%	0.00%
31-Dec-2018	09-Aug-2018	30-Jun-2018	1	9,822	1,324	651	651	-	156,908	- %	6.63%	0.41%	200,650	4.90	1.59	0.33	0.11	0.00	0.00	0.7820	0.25	-56.92%	- %	29-Jun-2018	0.38	7.76	117.12	0.49	0.85%	0.00%	09-Aug-2018	0.36	7.35	110.96	0.46	0.90%	0.00%
31-Dec-2017	28-Feb-2018	31-Dec-2017	2	246	1,511	1,511	1,511	-	10,834	- %	614.23%	13.95%	180,570	0.14	0.04	0.01	0.25	0.00	0.00	0.0600	0.02	- %	37,875.00%		0.00	0.00	0.00	0.00	0.00%	0.00%	28-Feb-2018	0.31	227.55	37.05	5.17	2.70%	0.00%
31-Dec-2017		30-Jun-2017	1	0	0	0	0	-	-	- %	- %	- %	2	-	-	0.00	0.00	0.00	0.00	-	-	- %	- %		0.00	0.00	0.00	0.00	0.00%	0.00%		0.00	0.00	0.00	0.00	0.00%	0.00%
31-Dec-2016		31-Dec-2016	2	0	-4	-4	-4	-	0	- %	0.00%	- %	2	-	-	-200.00	0.00	0.00	0.00	0.0000	0.00	- %	- %		0.00	0.00	0.00	0.00	0.00%	0.00%		0.00	0.00	0.00	0.00	0.00%	0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.

Social Forum

Comment

Be the first to like this.

sptay Health company specialising in women 's health and IVF.

27/02/2018 11:34 PM

lcchoo Room to grow

28/02/2018 6:09 AM

lcchoo Today got some volume.. looking forward to grow

09/03/2018 6:15 PM

lcchoo Wow.. rm0.50 now... still going up and strong

27/12/2018 3:59 PM

Jeremy Ting It's a good stock

27/06/2019 10:19 AM

lcchoo Ya.. now touching rm1.00

21/10/2019 2:46 PM

lcchoo With loads of govt support and initiativea to promote ferrility treatment, which is their core strength.. this counter will only gain further

21/10/2019 9:54 PM

bschen3 is this company still alive?

21/04/2021 10:38 AM

lcchoo this company is focused on Assisted reproductive technology with high success rate on their IVF treatment.. definitely a diamond in the making..

27/05/2021 7:48 AM

lcchoo Hurray..just received bonus share issue.. 2 for 1.. looking forward to another climb..

23/10/2021 11:54 AM

Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$â¬Â£Â¥ This counter listed on IPO at 25 sen per share in 2018.
After 2 for 1 bonus, it is now 57 sen per share.
The initial investors have seen their investment per share rising from 25 sen per share to 57 x 3 = 171 sen per share (a 6 multi-bagger).
Dividends were distributed annually.

MHCare is in assisted reproductive technology. It is among the leaders providing this service in Malaysia. It benefits from health tourism which is promoted by the Malaysian government. It is growing its services in various parts of Malaysia consistently.

15/02/2022 5:46 PM

lcchoo This company is having a great run due to their focus in the niche market which involved fertility treatment coupled with their targeted expansion and coverage This has lead to a great 2H 2021 thus ending another strong full year 2021.
With a capable management who has clear objectives for strong growth and sustainability, will look forward to another grear 2022 and beyond..

23/02/2022 1:17 PM

Chunghou Saw Metro Healthcare featured in TIME Magazine Person Of The Year 2022/2023. Kudos https://link.emagazines.com/?t=6DAE8BFD-8365-47B6-A3DA-9CBA14D36A7C

04/01/2023 12:32 PM

lcchoo Hurray, today's announcement of their move to ACE

25/05/2023 8:19 PM

new2stockmarket Any news on this stock?

20/01/2024 9:00 PM